Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,430 public trials 2,855 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Not yet recruiting

A Open-Label Phase in Participants With Multiple Myeloma

NCT07764861

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Evaluation of Iopofosine I 131 vs. R-CD in WM Patients

NCT07766421

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study of Rusfertide in Adults With Polycythemia Vera in China

NCT07765602

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Liver Biopsy Following Gene Therapy For Hemophilia

NCT05932914

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Not yet recruiting

Real World Asparaginase Therapy Toxicity

NCT07008027

Conditions: Chemically-Induced Disorders, Drug Toxicity, Drug-Related Side Effects and Adverse Reactions, +12 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Not yet recruiting

Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies

NCT07759661

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations: IRCCS Ospedale San Raffaele Milan, MI, Italy

View Trial Details

Not yet recruiting

mNGS for IFD in Patients With Hematological Malignancies

NCT07763184

Conditions: Bacterial Infections and Mycoses, Hematologic Diseases, Hematologic Neoplasms, +8 more
Locations: Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

NCT07301424

Conditions: Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia, Hematologic Diseases, +10 more
Locations: University of Alberta Edmonton, Alberta, Canada

View Trial Details

Not yet recruiting

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

NCT07178912

Conditions: Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not yet recruiting

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

NCT07283640

Conditions: Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: MD Anderson Cancer Houston, Texas, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions